Response to Therapy, Treatment Intolerance and Tyrosine Kinase Inhibitor Cessation Eligibility in a Real-World Cohort of Chronic Myeloid Leukaemia Patients.

Keywords: TKI, CML, intolerance, treatment cessation, real-world

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text